Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 23, 2000

View Archived Issues

Immune Response synthesizes new factor VIII gene

Cantab makes steady progress during 1999

Reticulose cleared for clinical trials in Argentina

FDA advisory committee meeting canceled

OSI Pharmaceuticals makes forward strides during Q1 2000

NCI begins phase II trial of O6-benzylguanine/carmustine as glioma therapy

Biomira updates product pipeline

Gilead reviews progress in 1999

Oxigene to develop CA4P for eye, skin and joint disorders

Life-saving treatment for pulmonary hypertension in newborn babies featured in NEJM

New phenethylsulfones synthesized at Celgene useful for inflammation, etc.

Lilly's new 5-ht1f receptor antagonists covered by two European patents

Cell Pathways presents apoptosis-promoting compounds

Gene therapy improves age-related cardiac disorder in rats

New compounds with ampakine-like activity in development at Lilly

Novirio claims large group of HIV RT inhibitors

Cantharidin analogues as protein phosphatase inhibitors: use in cancer therapy

Antiparasitic artemisinin derivatives designed at Hong Kong university

New antiepileptic Diastat available in Canada for ARS

Early clinical trial in Japan demonstrates safety, favorable pharmacokinetics of CGS-19755

CPMP issues positive opinion regarding PEG-Intron MAA

Antifungal activity of brasilinolide B described by Japanese research team

Switch Biotech files patent applications for wound-healing genes

Approvable letter issued by FDA for Texas Biotechnology's Novastan

Paladin licenses Uniprost to United Therapeutics in Canada

Trichobitacin: anti-HIV RIP purified from Chinese medicinal herb

Monsanto and P&U to hold special shareholder meetings to vote on proposed merger

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...